Dr Penny Kechagioglou

GenesisCare UK

Dr Penny Kechagioglou is a senior clinical oncology consultant with a diverse portfolio of clinical strategy, clinical governance, innovation and research. After qualifying as a doctor in Wales, she completed an internal medicine residency in UK, following which she completed and was awarded a CCT in Clinical Oncology (2010). Has worked as a consultant clinical oncologist in various UK NHS Trusts and has experience in managerial roles such as Chief Medical Officer at Genesis Care UK, Clinical Governance Lead for Oncology/Haematology in the NHS, Vice Chair and member of Research Ethics Committees, NICE Health Technology Assessment Committee member, Specialist advisor for the CQC and the Healthcare Ombudsman. Dr Kechagioglou is a principal investigator and co-investigator in many national and international breast cancer clinical trials and has a medical education portfolio as Senior Clinical Lecturer, Academic mentor, Medical tutor and postgraduate GP Educator. She has completed an MSc in Public Health and an MBA and she is currently working toward a Doctorate in Business Administration.

dont miss

Breast cancer Service of the Future: a service transformation

The Breast Service of the Future is a service transformation project, which aims at combining all elements of excellent cancer care from diagnosis to survivorship. At times of financial and workforce pressures, there should not be any compromise in the quality, efficiency and access to world class cancer care. Cancer care should be patient-focused and individualised, from diagnosis through to surgery, radiotherapy, chemotherapy and surveillance. The presentation will take the audience the why and how this was achieved by a single private organization.


  • Dr. Henrik Harling: Speaking at the Oncology Convention

    Dr. Henrik Harling

    IndiTreat® functional profiling, to match effective cancer drug treatment to individual cancer patients

  • Dr Abeer Shaaban: Speaking at the Oncology Convention

    Dr Abeer Shaaban
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

  • Lucinda Billingham: Speaking at the Oncology Convention

    Lucinda Billingham
    University of Birmingham - Cancer Research Clinical Trials Unit

    National Lung Matrix Trial: testing multiple novel targeted treatments

  • Dr Paul Fenton: Speaking at the Oncology Convention

    Dr Paul Fenton
    University Hospital Southampton NHS Foundation Trust

    Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment (RAMPART) clinic

  • Islam Elkonaissi: Speaking at the Oncology Convention

    Islam Elkonaissi
    The Royal Marsden NHS Foundation Trust

    The Multi-Specialty Challenge of Cancer Care